引导式在线失眠认知行为疗法「i-Sleep youth」能否改善儿童癌症后青少年失眠:MICADO随机对照试验方案
本研究为全国性随机对照试验方案,比较引导式在线失眠认知行为疗法(iCBT-I)与等待列表对照在儿童癌症后12-30岁失眠患者中的效果。计划纳入70例,主要评估3个月和6个月时睡眠效率与失眠严重度等结局,干预组另随访至12个月。若有效,可为该人群失眠治疗指南提供依据。
要点
- 儿童癌症后失眠患病率26-29%,常伴疲劳、疼痛及心理问题,构成双重健康负担。
- iCBT-I「i-Sleep」在成人乳腺癌患者中有效,但儿科肿瘤人群效果未知。
- 本试验比较引导式iCBT-I与等待列表对照,评估3、6个月效果及12个月维持情况。
核心结论
- 引导式在线CBT-I对儿童癌症后青少年失眠的疗效尚待本随机对照试验验证。
- 若证实有效,可推动制定该人群失眠治疗指南,可能改善生活质量与健康。
研究设计与样本
- 全国性随机对照临床试验,比较引导式iCBT-I与等待列表对照,计划样本量n=70。
- 干预组在3、6个月评估后,另于12个月随访评估效果是否维持。
- 纳入12-30岁、诊断为(儿童期)癌症且末次治疗至少6个月后的失眠患者。
主要发现
- 原文为研究方案,尚未报告试验结果。
- 背景指出儿童癌症后失眠患病率为26-29%。
- i-Sleep在成人(乳腺癌)患者中显示有效,但在儿科肿瘤人群中的有效性未知。
关键数值与推荐
- 评估结局包括体动记录仪测量的睡眠效率、自报失眠严重度、睡眠与昼夜活动节律参数。
- 其他结局包括疲劳、健康相关生活质量、感知认知功能、慢性痛苦、抑郁和焦虑症状及干预可接受性。
- 干预组在3、6个月与等待列表对照比较,12个月评估干预后效果维持。
临床怎么用
- 若引导式iCBT-I有效,可将其纳入儿童癌症后青少年失眠的治疗指南。
- 在线引导式CBT-I有望提高该人群获得一线失眠治疗的可及性。
局限性
- 原文为研究方案,尚无疗效数据。
- 等待列表对照可能限制对长期效果的评估。
- 样本量n=70,统计效能需关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adolescents and young adults who had childhood cancer are at increased risk for insomnia, due to being critically ill during an important phase of their life for the development of good sleep habits. Insomnia is disabling and prevalent after childhood cancer (26-29%) and negatively impacts quality of life, fatigue, pain, and general functioning and is often associated with other (mental) health problems. Insomnia and a history of childhood cancer both increase the risk of adverse health outcomes, posing a double burden for adolescents who had childhood cancer. The first-line treatment for insomnia is cognitive behavioral therapy for insomnia (CBT-I). However, access to this type of care is often limited. The guided online CBT-I treatment "i-Sleep" has been developed to facilitate access via online care. i-Sleep is shown effective in adult (breast cancer) patients, but it is unknown if iCBT-I is effective in pediatric oncology. METHODS/DESIGN: We developed a youth version of i-Sleep. Our aim is to evaluate its effectiveness in a national randomized-controlled clinical trial comparing iCBT-I to a waiting-list control condition at 3 and 6 months (n = 70). The intervention group will be also assessed at 12 months to see whether the post-test effects are maintained. Adolescents and young adults aged 12-30 years with insomnia, diagnosed with (childhood) cancer, currently at least 6 months since their last cancer treatment will be eligible. Outcomes include sleep efficiency (actigraphic), insomnia severity (self-report), sleep and circadian activity rhythm parameters, fatigue, health-related quality of life, perceived cognitive functioning, chronic distress, depressive and anxiety symptoms, and intervention acceptability. DISCUSSION: Insomnia is prevalent in the pediatric oncology population posing a double health burden for adolescents and young adults who had childhood cancer. If guided iCBT-I is effective, guidelines for insomnia can be installed to treat insomnia and potentially improve quality of life and the health of adolescents and young adults who had childhood cancer. TRIAL REGISTRATION: NL7220 (NTR7419; Netherlands Trial register). Registered on 2 August 2018.
引用
- Peersmann SHM, van Straten A, Kaspers GJL, et al. Does the guided online cognitive behavioral therapy for insomnia "i-Sleep youth" improve sleep of adolescents and young adults with insomnia after childhood cancer? (MICADO-study): study protocol of a randomized controlled trial. Trials. 2021. PMID: 33902701. doi:10.1186/s13063-021-05263-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。